Syon Capital’s GoodRx Holdings GDRX Stock Holding History

Syon Capital’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-25,000	Closed	-$168K	–	479
2023 Q4	$168K	Buy	+25,000	New	+$141K	0.01%	472

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

Syon Capital's GDRX Position: Q1 2024 in Review

Syon Capital sold out of GoodRx Holdings (GDRX) in Q1 2024, closing a stake of 25,000 shares — an estimated $168K sold.

Syon Capital first reported a position in GDRX in Q4 2023 and held it in 1 quarter. The position peaked at $168K in Q4 2023. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2024.

Syon Capital reported no remaining GoodRx Holdings position as of Q1 2024 after selling out during the quarter.
Syon Capital sold 25,000 GoodRx Holdings shares in Q1 2024, an estimated $168K.
Syon Capital first reported a position in GoodRx Holdings in Q4 2023 and held it in 1 quarter.
Syon Capital's GoodRx Holdings position peaked at $168K in Q4 2023.
159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2024.

Based on Syon Capital's 13F filing for Q1 2024, filed 14 May 2024.